GeoWealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$836K Buy
34,730
+2,346
+7% +$61.4K 0.03% 368
2026
Q1
$909K Buy
32,384
+9,382
+41% +$250K 0.03% 315
2025
Q4
$573K Sell
23,002
-6,631
-22% -$167K 0.02% 408
2025
Q3
$755K Buy
29,633
+11,592
+64% +$286K 0.03% 363
2025
Q2
$437K Buy
18,041
+6,101
+51% +$142K 0.02% 431
2025
Q1
$303K Sell
11,940
-8,823
-42% -$231K 0.01% 551
2024
Q4
$551K Sell
20,763
-13,981
-40% -$379K 0.02% 448
2024
Q3
$1.01M Sell
34,744
-3,042
-8% -$88.7K 0.04% 308
2024
Q2
$1.06M Buy
37,786
+9,147
+32% +$252K 0.05% 256
2024
Q1
$795K Buy
28,639
+6,009
+27% +$167K 0.03% 338
2023
Q4
$651K Buy
22,630
+20,658
+1,048% +$624K 0.05% 280
2023
Q3
$65K Buy
1,972
+915
+87% +$32.4K 0.01% 373
2023
Q2
$39K Sell
1,057
-134
-11% -$5.22K ﹤0.01% 339
2023
Q1
$49K Buy
+1,191
New +$51.4K 0.01% 289

Other funds holding PFE

GeoWealth Management's PFE Position: Q2 2026 in Review

GeoWealth Management increased its Pfizer (PFE) stake by 7.2% in Q2 2026, buying an estimated $61.4K and bringing the position to 34,730 shares worth $836K. The position accounts for 0.03% of the portfolio, ranked #368.

GeoWealth Management first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.06M in Q2 2024. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • GeoWealth Management held 34,730 shares of Pfizer worth $836K as of Q2 2026.
  • GeoWealth Management bought 2,346 Pfizer shares in Q2 2026, an estimated $61.4K.
  • Pfizer made up 0.03% of GeoWealth Management's portfolio in Q2 2026, its #368 holding.
  • GeoWealth Management first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • GeoWealth Management's Pfizer position peaked at $1.06M in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.